1 CASE STUDY EPAM’S REAL-TIME CLINICAL DATA PULLING SOLUTION HELPS ELIMINATE DRUG FAILURES IN R&DCASE STUDY: EPAM’S REAL-TIME CLINICAL DATA PULLING SOLUTION HELPS SNUFF OUT DRUG FAILURES IN R&D The client is a multinational pharmaceutical and biologics company with operations in over 100 countries. Its portfolio of products spans major disease areas such as cancer, inflammation, cardiovascular, infection, gastrointestinal, neuroscience, and respiratory. THE CHALLENGE: ENABLE REAL-TIME CLINICAL DATA INVESTIGATION IN PHARMA R&D Before the engagement, EPAM’s client had already established a robust approach to clinical trial safety management, putting into place multiple standard procedures to review data and mandate the reporting of serious adverse events. While this data was being

Join for free to read